WELLS FARGO & COMPANY/MN - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 52 filers reported holding HAEMONETICS CORP MASS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$16,552,593
+16.4%
19,063,000
+15.1%
0.01%
+25.0%
Q2 2023$14,220,359
+64.9%
16,564,000
+63.5%
0.00%
+100.0%
Q1 2023$8,622,291
+40.3%
10,131,000
+37.2%
0.00%0.0%
Q4 2022$6,146,146
+5.6%
7,384,000
+1.7%
0.00%0.0%
Q3 2022$5,819,000
+1.3%
7,259,0000.0%0.00%0.0%
Q2 2022$5,745,000
+5762.2%
7,259,000
+6212.2%
0.00%
Q1 2022$98,000115,0000.00%
Other shareholders
HAEMONETICS CORP MASS shareholders Q3 2023
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,705,0001.15%
Context Capital Management, LLC 14,558$12,6601.02%
Quaero Capital S.A. 1,200,000$1,042,4400.99%
READYSTATE ASSET MANAGEMENT LP 22,200,000$19,369,5000.97%
DeepCurrents Investment Group LLC 24,371,000$21,212,5170.92%
ADVENT CAPITAL MANAGEMENT /DE/ 39,904,000$34,816,2400.81%
SSI INVESTMENT MANAGEMENT LLC 10,872,000$9,431,4620.77%
Empyrean Capital Partners, LP 13,500,000$11,696,9590.72%
MACKAY SHIELDS LLC 29,294,000$25,825,1100.71%
Aequim Alternative Investments LP 20,500,000$17,886,2500.68%
View complete list of HAEMONETICS CORP MASS shareholders